

Can't find Uceris at your pharmacy? Learn about proven alternatives like Mesalamine, Hydrocortisone foam, and Prednisone for ulcerative colitis.
If you've been trying to fill your Uceris prescription and keep running into dead ends, you're probably wondering: What else can I take?
The short answer is that several effective alternatives exist for treating ulcerative colitis. But switching medications isn't something you should do on your own — it's a conversation you need to have with your doctor.
In this post, we'll cover what Uceris is, how it works, and walk through the most common alternatives your doctor might consider if Uceris isn't available.
Uceris is the brand name for Budesonide, a locally-acting corticosteroid. It's FDA-approved for inducing remission in adults with mild to moderate ulcerative colitis (UC).
Uceris comes in two forms:
What makes Budesonide special is its high topical activity with low systemic absorption. When you take Uceris, the medication works directly on the inflamed tissue in your colon. About 90% of it is metabolized by the liver before it reaches the rest of your body. This means you get strong anti-inflammatory effects where you need them with fewer of the whole-body side effects that come with steroids like Prednisone.
Uceris reduces inflammation by suppressing pro-inflammatory chemicals (cytokines), preventing immune cells from migrating to the inflamed area, and reducing the leakiness of blood vessels in the colon wall.
There are several reasons you might need to look beyond Uceris:
Whatever the reason, it's important to know your options.
Brand names: Lialda, Apriso, Pentasa, Delzicol, Canasa (suppositories), Rowasa (enema)
Mesalamine is the first-line treatment for mild to moderate ulcerative colitis and is the most commonly prescribed alternative to Uceris. In fact, many insurance plans require you to try Mesalamine before they'll approve Uceris.
How it works: Mesalamine is a 5-aminosalicylic acid (5-ASA) that works locally in the colon to reduce inflammation. It has a different mechanism than corticosteroids — it blocks the production of prostaglandins and leukotrienes, which are chemicals that drive the inflammatory process in UC.
Key differences from Uceris:
Typical cost: $50 to $400 per month depending on formulation and whether you use generic or brand-name.
Best for: Patients with mild UC who need a long-term maintenance medication, or those who haven't tried a 5-ASA drug yet.
Brand names: Cortifoam (foam), Cortenema (enema)
If you've been using Uceris rectal foam specifically, Hydrocortisone rectal products are the most direct alternative.
How it works: Hydrocortisone is a corticosteroid that works similarly to Budesonide by suppressing the immune response and reducing inflammation. However, Hydrocortisone has more systemic absorption than Budesonide, meaning more of the drug reaches your bloodstream and the rest of your body.
Key differences from Uceris:
Typical cost: $200 to $600 per month.
Best for: Patients who need a topical rectal corticosteroid and can't find Uceris foam. Usually recommended for short-term use during flares.
Brand names: Deltasone, Prelone, and various generics
Prednisone is the go-to systemic corticosteroid for moderate to severe UC flares. It's widely available, inexpensive, and very effective at controlling acute inflammation.
How it works: Prednisone is a powerful anti-inflammatory that suppresses the immune system throughout the entire body. Unlike Budesonide, it has high systemic bioavailability, which makes it very effective but also causes more side effects.
Key differences from Uceris:
Typical cost: $5 to $20 per month (generic).
Best for: Patients experiencing a moderate to severe UC flare who need fast, reliable relief. Not a long-term solution.
Generic available: Yes
Entocort EC contains the same active ingredient as Uceris — Budesonide — but it's formulated differently. The delayed-release capsule is designed to release the drug in the ileum (the last part of the small intestine) and the right side of the colon.
How it works: Same mechanism as Uceris, but the release site is different. Entocort EC is primarily FDA-approved for Crohn's disease affecting the ileum and ascending colon, not ulcerative colitis. However, some doctors prescribe it off-label for UC, particularly when it involves the right colon.
Key differences from Uceris:
Typical cost: $100 to $400 per month (generic).
Best for: Patients who respond well to Budesonide and whose UC affects the right colon. Discuss with your gastroenterologist.
The right alternative depends on several factors:
This is a conversation to have with your gastroenterologist. Don't switch medications on your own, and never stop Uceris abruptly without medical guidance — corticosteroids need to be tapered gradually to avoid adrenal crisis.
If Uceris is the medication that works best for you, don't give up on finding it. Use Medfinder to search for pharmacies with Uceris in stock near you. You can also read our guide on how to find Uceris in stock for more tips.
And if cost is a barrier, check out our post on saving money on Uceris — there are manufacturer coupons and patient assistance programs that can significantly reduce your out-of-pocket cost.
Not being able to fill your Uceris prescription is stressful, especially when you're managing a condition like ulcerative colitis where uncontrolled inflammation can lead to serious complications.
The important thing is to keep treating your UC. Whether that's with Mesalamine, Hydrocortisone, Prednisone, or another Budesonide formulation, effective options exist. Work with your doctor to find the right fit, and use tools like Medfinder to stay on top of medication availability.
Your health comes first — and there's always a path forward.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.